Goldstein: Expect More Litigation After Myriad

June 13 (Bloomberg Law) -- Tom Goldstein, partner at Goldstein & Russell, PC and founder of SCOTUSblog, talks with Bloomberg Law's Lee Pacchia about the United States Supreme Court's decision in the Association for Molecular Pathology v. Myriad Genetics, Inc. case. At issue was whether patents may be granted on parts of the human body. He also explores whether Justice Scalia's concurrence raises doubts whether he believes in molecular biology, and where patent litigation will head in the wake of the decision. Bloomberg Law is a sponsor of SCOTUSblog.
Rubenstein: U.S. Can Expect Recession in 1-3 Years
29:25 - David Rubenstein, co-founder and co-chief executive officer at The Carlyle Group, discusses his call for 1-2 percent U.S. growth in the next year and explains why the country can expect a recession within the next three years. He speaks on "Bloomberg ‹GO›" (Source: Bloomberg)
  • David Rubenstein Warns of Slow U.S. Growth, Recession
  • Central Banks and the World of Single Digit Returns
  • HSBC Prepares for Disinflation in the Bond Market